Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 5, 2001, Pages 1226-1234

  Martinez, Alvaro A ^a   Yan, Di ^a   Lockman, David ^a   Brabbins, Donald ^a   Kota, Kamal ^a   Sharpe, Michael ^a   Jaffray, David A ^a   Vicini, Frank ^a   Wong, John ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Adaptive radiotherapy; Dose escalation; IMRT; Prostate cancer; Radiotherapy; Treatment image feedback

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DISEASE CONTROL; DOSIMETRY; TUMORS;

DOSE ESCALATION;

RADIOTHERAPY;

ACCURACY; ARTICLE; BEAM THERAPY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; EVALUATION; HUMAN; HYPOTHESIS; INTOXICATION; IRRADIATION; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; REDUCTION; SAFETY; TREATMENT OUTCOME; TREATMENT PLANNING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, HORMONAL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; HUMANS; MALE; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RECTUM; SEMINAL VESICLES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035424531     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01552-8     Document Type: Article

References (42)

1. The management of clinically localized prostate cancer
2. Prostate cancer, the magnitude of the problems in the United States
3. External beam radiation therapy for clinically localized prostate cancer: Patterns of care studies in the United States
4. The role of androgen deprivation in the definitive management of clinically localized prostate cancer treated with radiation therapy
5. Status of radiation treatment of prostate cancer at Stanford University
6. Prognostic factors in carcinoma of the prostate analysis of RTOG Study 75-06
7. Radiation therapy for localized prostate carcinoma: Experience at the Massachusetts General Hospital (1973-1981)
8. Carcinoma of the prostate: Results of post-irradiation biopsy
9. Boost treatment of the prostate using shaped, fixed fields
10. The steepness of the dose-response curve in radiation therapy
11. The effect of dose on local control of prostate cancer
12. Dose-incidence curves for tumor control and normal tissue injury, in relation to the response of clonogenic cells
13. The relation between tumor lethal doses and the radiosensitivity of tumor cells
14. Tumor control in definitive irradiation of localized carcinoma of the prostate
15. When and how can we improve precision in radiotherapy?
16. Dose escalation for stage C (T3) prostate cancer: Minimal rectal toxicity observed using conformal therapy
17. Three-dimensional conformal treatment: A new frontier in radiation therapy
18. Multi-dimensional treatment planning: I. Delineation of anatomy
19. Multi-dimensional treatment planning: II. Beam's eye view, back projection through CT sections
20. A computerized three-dimensional treatment planning system utilizing interactive colour graphics
21. A comprehensive three-dimensional radiation treatment planning system
22. Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer
23. The use of on-line image verification to estimate the variation in radiation therapy dose delivery
24. Analysis of prostate and seminal vesicle motion: Implications for treatment planning
25. Variation in prostate position qualification and implications for three-dimensional conformal treatment planning
26. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder and rectum during a course of external beam radiation therapy
27. Adaptive radiation therapy
28. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process of prostate cancer
29. Combination of prostate-specific antigen, clinical stage, and gleason score to predict pathological stage of localized prostate cancer
30. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histiograms
31. Dose Escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
32. Clinical implementation of an adaptive process for the treatment of prostate cancer with intensity modulated beams
33. Can modest escalations of dose be detected as increased tumor control?
34. Radiation dose-response of human tumors
35. Interim report of image-guided conformal high dose rate brachytherapy for patients with unfavorable prostate cancer: The William Beaumont phase II dose-escalating trial
36. The effect of local control on metastatic dissemination in carcinoma of the prostate: Long-term results in patients treated with 125-I implantation
37. Potential benefit of improved local tumor control in-patient with prostate carcinoma
38. Prognostic significance of pelvic recurrence and distant metastasis in prostate carcinoma following definitive radiotherapy
39. The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy
40. Can modest escalations of dose be detected as increased tumor control?
41. Inter-tumor heterogeneity and radiation dose control curves
42. Cone-beam tomographic guidance of radiation field placement for radiotherapy of the prostate